| Product Name | MF | CAS | Details |
|---|
| 2,3-Difluoro-2,3-dimethylbutan-1-amine hydrochloride | 2361644-60-0 | Details |
| (1R,5S,6R)-(3-Azabicyclo[3.1.0]hex-6-yl)methanol | C6H11NO | 134575-13-6 | Details |
| 1-Chloro-2-fluoro-4-(methoxymethoxy)benzene | C8H8ClFO2 | 775334-11-7 | Details |
| Pimodivir | C20H19F2N5O2 | 1629869-44-8 | Details |
| S-Desmethyl-S-(2-hydroxy-2-methylpropyl) rosuvastatin calcium | C25H36CaFN3O7S | 1714147-47-3 | Details |
| 3-(6-Methylpyridin-2-yl)propan-1-amine | C9H14N2 | 1000510-50-8 | Details |
| 1-(6-Methylpyridin-2-yl)ethanamine | C8H12N2 | 58088-67-8 | Details |
| Ac-CVQHHRERKRASKSSKHSMS-OH | Details |
| 2-(4-Methanesulfonylpiperazin-1-yl)ethan-1-amine | C7H17N3O2S | 1018305-83-3 | Details |
| 1-(Pyrrolidin-3-yl)-1H-pyrazole | C7H11N3 | 1196156-80-5 | Details |
| Methoxymethyl 2-hydroxypropanoate | C5H10O4 | 1697640-97-3 | Details |
| 1,2-Dihydroxy-3-nitroanthraquinone | C14H7NO6 | 568-93-4 | Details |
| 4-Chloro-2-cyclopropyl-5-iodo-6-(methoxymethyl)pyrimidine | C9H10ClIN2O | 1525519-07-6 | Details |
| SHH antibody | Details |
| 1-(3-Aminopropoxy)-4-tert-butyl-2-methylbenzene hydrochloride | C14H24ClNO | 1394042-07-9 | Details |
| PROTAC CDK2/9 Degrader-1 | C40H41N13O7 | 2408641-24-5 | Details |
| Spiro[bicyclo[2.2.1]heptane-2,1'-cyclobutane]-3'-amine hydrochloride | 2253632-87-8 | Details |
| Methyl 2-{[(3-fluorophenyl)methyl]amino}acetate hydrochloride | C10H13ClFNO2 | 1193390-44-1 | Details |
| Chromogranin C antibody | Details |
| Rabeprazole | C18H21N3O3S | 117976-89-3 | Details |
| Quinolin-5-yl-methylamine | C10H10N2 | 58123-57-2 | Details |
| HXB2 gag NO-121/aa481 - 495 | C80H128N20O23 | Details |
| 3-[3-(Dimethylamino)propyl]-1,3-oxazolidin-2-one | 807290-95-5 | Details |
| 3-Ethenylazetidine, trifluoroacetic acid | C7H10F3NO2 | 1630907-01-5 | Details |
| α-Conotoxin MI | C58H88N22O17S4 | 88217-10-1 | Details |
| 3-Methyl-5-(2-methylphenyl)-1H-1,2,4-triazole | C10H11N3 | 37894-98-7 | Details |
| C11orf49 antibody | Details |
| Elipovimab | 2101210-43-7 | Details |
| 1,2,3,4-Tetrahydroquinoline-1-carboximidamide | C10H13N3 | 764590-94-5 | Details |
| 5-Benzoyl-1H-1,3-benzodiazole | C14H10N2O | 82326-53-2 | Details |
| N-(3,4-Dichlorophenyl)benzofuran-2-carboxamide | C15H9Cl2NO2 | 420097-22-9 | Details |
| Tolvaptan gamma-hydroxybutanoic acid impurity | C26H25ClN2O5 | 1346599-75-4 | Details |
| 4-Methyl-3-[(4-methylpyridin-2-yl)oxy]aniline | C13H14N2O | 1249485-96-8 | Details |
| Caprinone | C19H38O | 504-57-4 | Details |
| 4-(Methoxymethyl)-2-methylbenzene-1-sulfonamide | C9H13NO3S | 1549134-68-0 | Details |
| 3-(1-Amino-2,2,2-trifluoroethyl)benzonitrile hydrochloride | C9H8ClF3N2 | 2089258-17-1 | Details |
| S-Acetyl-PEG3-azido | C10H19N3O4S | 1310827-26-9 | Details |
| AZ 10417808 | C18H13Cl2N5O4 | 331645-84-2 | Details |
| tert-Butyl N-(2-amino-5-cyanophenyl)carbamate | C12H15N3O2 | 1824298-66-9 | Details |
| Dexamethasone oxetanone | C22H27FO4 | 4089-36-5 | Details |
| 1-(4-chlorophenyl)imidazolidin-2-one | C9H9ClN2O | 14088-99-4 | Details |
| 1-(6-Bromopyridin-3-yl)-N-methylmethanamine | C7H9BrN2 | 120740-04-7 | Details |
| Tryptone | 91079-40-2 | Details |
| N-Fmoc-O-a-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-b-D-glucopyranosyl-b-1-4-2,3,6-tri-O-acetyl-a-D-mannopyranosyl)-L-threonine | Details |
| beta-D-Galactose pentaacetate | C16H22O11 | 4163-60-4 | Details |
| N-(2,3-Dihydro-1H-isoindol-5-ylmethyl)acetamide hydrochloride | C11H15ClN2O | 1803588-58-0 | Details |
| Roburic acid | C30H48O2 | 6812-81-3 | Details |
| (2-Cyclopropyl-1,3-oxazol-5-yl)methanamine | C7H10N2O | 1226290-67-0 | Details |
| 2-{1-[(tert-Butoxy)carbonyl]pyrrolidin-3-yl}-2-methylpropanoic acid | C13H23NO4 | 1783329-94-1 | Details |
| CRAC inhibitor 44 | C22H19F2N3OS | 944917-72-0 | Details |
| 2'-Azido-2'-deoxyguanosine-5'-triphosphate lithium salt - 100mM aqueous solution | C10H11Li4N8O13P3 | Details |
| EFTUD2 antibody | Details |
| 5-(5-Bromothiophen-2-yl)-1,2,4-triazin-3-amine | C7H5BrN4S | 1183278-60-5 | Details |
| 5H,6H,7H-Cyclopenta[b]pyridin-6-amine dihydrochloride | C8H12Cl2N2 | 1355328-35-6 | Details |
| Cesium formate | CH3CsO2 | 3495-36-1 | Details |
| 5-(3-Methylphenyl)-4-propyl-4H-1,2,4-triazole-3-thiol | C12H15N3S | 885460-02-6 | Details |
| 4-(4-Fluorobenzenesulfonyl)-2-(4-fluorophenyl)-5-(propane-1-sulfonyl)-1,3-oxazole | C18H15F2NO5S2 | 891021-50-4 | Details |
| LRRC33 Blocking Peptide | Details |
| 2-Amino-3-(dimethylamino)-2-methylpropanoic acid | C6H14N2O2 | 1249298-70-1 | Details |
| 1-(4-Acetylbenzenesulfonyl)piperidine-2-carboxylic acid | C14H17NO5S | 809240-69-5 | Details |
| 3-(2,4-Dimethylphenyl)propan-1-amine | C11H17N | 377083-88-0 | Details |
| 4-Methanesulfonylmorpholine-2-carbohydrazide | C6H13N3O4S | 1803597-61-6 | Details |
| Septin 3 | Details |
| 3-o-Cis-p-coumaroylmaslinic acid | C39H54O6 | 69297-40-1 | Details |
| 4-(4-chlorophenyl)-4-oxo-2-((3-pyridylmethyl)amino)butanoic acid | C16H15ClN2O3 | 1031208-58-8 | Details |
| 2-[(2-Cyanophenyl)sulfanyl]acetic acid | C9H7NO2S | 98589-44-7 | Details |
| 4-Phenoxy-1,3-benzothiazol-2-amine | C13H10N2OS | 77859-33-7 | Details |
| 5-(Methoxymethyl)-3-methyl-1H-1,2,4-triazole | C5H9N3O | 89417-85-6 | Details |
| H-SPYVESEDAPPQKK-OH | Details |
| tert-Butyl 2-(3,5-dioxothiomorpholin-2-yl)acetate | 2408963-62-0 | Details |
| GDP-2-deoxy-2-fluoro-L-fucose ammonium salt | C16H27FN6O14P2 | 209005-22-1 | Details |
| 1-[(4-Fluorophenyl)methyl]-2-oxocyclopentane-1-carbonitrile | C13H12FNO | 1493457-80-9 | Details |
| 3,3-Dimethyl-1-[2-(trifluoromethyl)phenyl]butan-2-amine hydrochloride | C13H19ClF3N | 1803584-22-6 | Details |
| Lappaol F | C40H42O12 | 69394-17-8 | Details |
| 4-[(Cyclopropylamino)methyl]-2-methoxyphenol hydrochloride | C11H16ClNO2 | 1197796-77-2 | Details |
| Anti G-Protein: Galpha olf (23-38), humanSerum | Details |
| Influenza B antibody (FITC) | Details |
| 2-(3-Chlorophenyl)-2H-pyrazol-3-ylamine | C9H8ClN3 | 15001-15-7 | Details |
| H-GPPAAAPGHPLAPGPHPAAPSSWGPRPRRY-OH | Details |
| 3-(Chlorosulfonyl)-5-nitrobenzoic acid | C7H4ClNO6S | 860596-66-3 | Details |
| 1-phenyl-4-(prop-2-yn-1-yl)piperazine | C13H16N2 | 21057-45-4 | Details |
| N,N-Dimethyl-2-(piperidin-4-yl)acetamide hydrochloride | C9H19ClN2O | 1443980-79-7 | Details |
| 3-Ethoxy-4-hydroxybenzylamine hydrochloride | C9H14ClNO2 | 105026-85-5 | Details |
| 5-(2-Methoxy-1,1-dimethyl-ethyl)-isoxazol-3-ylamine | C8H14N2O2 | 93509-70-7 | Details |
| 3-Amino-4-(ethylamino)benzonitrile | C9H11N3 | 143174-02-1 | Details |
| (S)-1-Isopropyl-5-oxopyrrolidine-2-carboxylic acid | C8H13NO3 | 928063-85-8 | Details |
| 3-Benzyl-3-azabicyclo[3.1.1]heptan-6-one hydrochloride | C13H16ClNO | 1803581-83-0 | Details |
| CDK7/9 tide Substrate | Details |
| TANK protein | Details |
| Methyl 4-(difluoromethyl)piperidine-4-carboxylate hydrochloride | C8H13F2NO2.ClH | 2260937-13-9 | Details |
| 2-(Cyclopent-3-en-1-yl)ethan-1-amine hydrochloride | 2126176-81-4 | Details |
| 3-[(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl]aniline hydrochloride | C12H15BrClN3 | 1049752-47-7 | Details |
| 4-(1,2,4-Oxadiazol-3-yl)piperidine hydrochloride | C7H12ClN3O | 1384079-72-4 | Details |
| 5-chloro-2-(chloromethyl)pyrimidine hcl | C5H5Cl3N2 | 1427454-12-3 | Details |
| Tefinostat | C28H37N3O5 | 914382-60-8 | Details |
| 5-Cyano-3-indoxyl-beta-D-galactopyranoside | Details |
| 2-Amino-3-(1H-1,2,4-triazol-3-yl)propanoic acid dihydrochloride | C5H9ClN4O2 | 2260931-22-2 | Details |
| BXDC5 antibody | Details |
| (S)-3-Amino-3-(3,5-dimethylphenyl)propanoic acid hydrochloride | 2225126-95-2 | Details |
| 3-Methyl-2-oxo-1,2,3,4-tetrahydroquinazoline-6-carboxylic acid | C10H10N2O3 | 118621-07-1 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||